Trial Information

Summary: Evaluating Cognitive and neuropsychological effects of a Study Drug in children with Partial Seizures.

A 19-week, randomized, double-blind, multicenter, placebo-controlled safety study to evaluate the cognitive and neuropsyhcological effects of a study drug 20-60 MG/KG/DAY, divided in twice daily dosing, as adjunctive treatment in children 4-16 years old, inclusive, with refractory partial onset seizures.

Eligibility:

• Patients must be between 4 and 16 years of age.
• Have partial epilepsy, and on one or two other anti-epileptic medications that are not working optimally to control the seizures.

For more information,

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:44:36 AM